drugset / Trial / NCT01831440

Pharmacotherapy and Psychotherapy for MDD After Remission on Psychology and Neuroimaging

NCT01831440

Unknown 200 enrolled Nanjing Medical University
RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this study is to determine the level of residual symptoms and psychosocial factors affecting recovery of psychosocial functions in MDD patients who reach remission, and investigate the recovery process of psychosocial functions. The investigators suppose that even the patient is well-treated by drug,there are still many residual symptoms,and they also exist different degree of damage in the structure and functions of brain. CBT could help them obtain better recovery,especially in psychosocial functions.

Timeline

Start
2011-01
Primary completion
2014-01
Completion
2014-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Background Citalopram Small molecule
Background Escitalopram Small molecule
Background Fluoxetine Small molecule
Background Fluvoxamine Unknown
Background Paroxetine Small molecule
Background Sertraline Small molecule

Indications